DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

被引:100
|
作者
Lie, AK
Risberg, B
Borge, B
Sandstad, B
Delabie, J
Rimala, R
Onsrud, M
Thoresen, S
机构
[1] Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[2] Norwegian Canc Soc, Oslo, Norway
[3] Pathol Lab, Oslo, Norway
[4] Ullevaal Univ Hosp, Dept Gynecol, Oslo, Norway
[5] Canc Registry Norway, Inst Epidemiol Canc Res, Oslo, Norway
关键词
HPV; DNA; mRNA; CIN; carcinoma;
D O I
10.1016/j.ygyno.2005.02.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To compare DNA-based and mRNA-based methods for detection of high-grade cervical neoplasia in Norway. Methods. HPV prevalence was analyzed in 383 women with positive index cytology, selected from gynecology clinics. All patients were investigated by a new PAP smear, histology, and two commercially available HPV tests: Hybrid Capture II (Digene, Gaithersburg, MD) and the Pre Tect HPV-Proofer (NorChip AS). Cases with positive DNA test and negative mRNA test and cases with high-grade histology and negative HPV tests were retested with PCR and sequencing. We regarded the infection as latent or transient if sequencing revealed an HPV type included in both assays. Results. High-risk HPV was detected in 99.7% of the histological confirmed high-grade lesions (CIN2+) (290/291). The DNA test was positive in 95% (275/291), and the mRNA test was positive in 77% (225/291) of the histological confirmed high-grade lesions. All invasive carcinomas were mRNA positive. The DNA test was significantly more often positive in benign and low-grade lesions, some of which were found to be false positive due to cross-contamination with unrelated types. High-grade histology was detected in 83% of women with normal cytology and positive mRNA test. Latent or transient infections were detected in 11 low-grade and 12 high-grade preinvasive lesions. Sequencing revealed high-risk HPV types included only in the DNA test in 35 high-grade preinvasive lesions, HPV 52 and 58 were the most prevalent HPV types. Conclusions. These HPV tests have the potential to improve the detection rate of high-grade cervical neoplasia, with some limitations. The mRNA test seems to be more appropriate for risk-evaluation. Larger scale, population based studies are necessary to evaluate the predictive values of HPV testing in Norway. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 50 条
  • [11] Differences Between DNA- and RNA-Based Bacterial Communities in Marine Sediments
    Li M.-Y.
    Yang Y.-H.
    Mi T.-Z.
    He H.
    Zhen Y.
    Huanjing Kexue/Environmental Science, 2020, 41 (05): : 2485 - 2495
  • [12] Comparison of cytology, cervicography and human papillomavirus DNA detection in cervical intraepithelial neoplasia and cancer
    Choi, H
    Kim, S
    Byun, J
    10TH WORLD CONGRESS OF CERVICAL PATHOLOGY AND COLPOSCOPY, 1999, : 269 - 271
  • [13] HUMAN PAPILLOMAVIRUS AND CERVICAL NEOPLASIA
    RONE, R
    TEXAS MEDICINE, 1986, 82 (07) : 5 - 6
  • [14] Comparison of DNA- and RNA-based parallel sequencing approaches for the detection of MET Exon 14 skipping mutations
    Heydt, C.
    Pappesch, R.
    Rehker, J.
    Wagener, S.
    Ihle, M. A.
    Siemanowski, J.
    Buettner, R.
    Fassunke, J.
    Merkelbach-Bruse, S.
    VIRCHOWS ARCHIV, 2018, 473 : S288 - S288
  • [15] Human papillomavirus and cervical neoplasia
    da Rosa, Maria Ines
    Medeiros, Lidia Rosi
    Rosa, Daniela Dornelles
    Bozzeti, Mary Clarisse
    Silva, Fabio Rosa
    Silva, Bruno Rosa
    CADERNOS DE SAUDE PUBLICA, 2009, 25 (05): : 952 - 963
  • [16] Human papillomavirus and cervical neoplasia
    Einstein, MH
    Goldberg, GL
    CANCER INVESTIGATION, 2002, 20 (7-8) : 1080 - 1085
  • [17] VIRAL-INFECTION, HUMAN PAPILLOMAVIRUS DNA, AND CERVICAL NEOPLASIA
    SOUTTER, WP
    BRITISH MEDICAL JOURNAL, 1988, 296 (6624): : 789 - 789
  • [18] VIRAL-INFECTION, HUMAN PAPILLOMAVIRUS DNA, AND CERVICAL NEOPLASIA
    WALKER, P
    GILES, J
    GRIFFITHS, P
    BRITISH MEDICAL JOURNAL, 1988, 296 (6629): : 1127 - 1127
  • [19] HUMAN PAPILLOMAVIRUS STANDARDIZATION AND DNA CYTOPHOTOMETRY IN CERVICAL INTRAEPITHELIAL NEOPLASIA
    GOPPINGER, A
    BIRMELIN, G
    IKENBERG, H
    ELMENTHALER, U
    HILGARTH, M
    HILLEMANNS, HG
    WIED, GL
    JOURNAL OF REPRODUCTIVE MEDICINE, 1987, 32 (08) : 609 - 613
  • [20] Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: Association of HPV DNA and RNA-based methods
    Rosini, S.
    Zappacosta, R.
    Di Bonaventura, G.
    Caraceni, D.
    Pilla, D.
    Di Girolamo, G.
    Esposito, A.
    Orsini, T.
    Setta, S.
    Vizzino, M.
    Piccolomini, M.
    Piccolomini, R.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (02) : 341 - 347